FDA/CDC

FDA approves premixed, low-volume colon-cleansing solution


 

The Food and Drug Administration has approved a premixed sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution (Clenpiq) for cleansing of the colon in adults preparing to undergo colonoscopy, according to Ferring Pharmaceuticals.

The sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution is a relatively low-volume, premixed, cranberry-flavored solution, making it easier to use and more palatable for patients.

The oral solution is approved with two dosing options: split dose, one dose the evening prior and one dose the morning of the procedure, or the day before dose, which involves taking both doses the day prior to the procedure. Day before dosing is an alternative and should be used when split dosing is not appropriate. After each dose of sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution, clear liquids should be consumed based on the dosing recommendation. The American College of Gastroenterology recommends the split-dose regimen because of its improved cleansing quality of the colon and better tolerability of the liquid volume by patients.

Patients with impaired renal function should exercise caution if using sodium picosulfate, magnesium oxide, and anhydrous citric acid oral solution as it may effect renal function. A more comprehensive list of safety information is available at www.clenpiq.com.

Recommended Reading

AGA Clinical Practice Update: Treatment of fecal incontinence and defecatory disorders
MDedge Internal Medicine
Adjusting fecal immunochemical test thresholds improved their performance
MDedge Internal Medicine
VIDEO: Study supports close follow-up of patients with high-risk adenomas plus serrated polyps
MDedge Internal Medicine
Biologics during pregnancy did not affect infant vaccine response
MDedge Internal Medicine
Radiofrequency ablation improves stent patency in malignant biliary strictures
MDedge Internal Medicine
Fecal microbiota transplants by oral capsule noninferior to colonoscopy
MDedge Internal Medicine
PBC disease progression no worse for patients with concomitant NAFLD
MDedge Internal Medicine
FDA recommends voluntary recall of Limbrel
MDedge Internal Medicine
Elevated antiphospholipid antibodies in celiac disease unrelated to gluten
MDedge Internal Medicine
Tc-325 effective for immediate GI tumor bleeding
MDedge Internal Medicine